Varicella vaccination - the global experience

References

• Centers for Disease Control and Prevention. Varicella; The Pink Book (13th Edition). Available from: www.cdc.gov/vaccines/pubs/pinkbook/downloads/varicella.pdf. [Accessed on Dec 5th, 2016].
   Google Scholar
• Herman L, Levin MJ, Rehm S. Shedding Light on Shingles: the Power of Prevention. Am J Med. 2016;129:1137.
   PubMed Web of Science ®Google Scholar
• Varicella Vaccination in the European Union. Available from: http://ecdc.europa.eu/en/publications/Publications/Varicella-Guidance-2015.pdf. [Accessed on Dec 6th, 2016].
   Google Scholar
• Bozzola E, Bozzola M. Varicella complications and universal immunization. J Pediatr (Rio J). 2016;92:328–330.
   PubMed Web of Science ®Google Scholar
• Varicella and herpes Zoster vaccines. WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89:265–287.
   PubMedGoogle Scholar
• Shah SS, Wood SM, Luan X, et al. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010;29:199–204.
   PubMed Web of Science ®Google Scholar
• Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011;128:214–220.
   PubMed Web of Science ®Google Scholar
• Boelle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect. 2002;129:599–606.
   PubMed Web of Science ®Google Scholar
• Helmuth IG, Poulsen A, Suppli CH, et al. Varicella in Europe-A review of the epidemiology and experience with vaccination. Vaccine. 2015;33:2406–2413.
   PubMed Web of Science ®Google Scholar
• Hobbelen PH, Stowe J, Amirthalingam G, et al. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013. J Infect. 2016;73:241–253.
   PubMed Web of Science ®Google Scholar
• Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–1376.
   PubMed Web of Science ®Google Scholar
• Widgren K, Giesecke J, Lindquist L, et al. The burden of chickenpox disease in Sweden. BMC Infect Dis. 2016;16:666.
   PubMed Web of Science ®Google Scholar
• Banz K, Wagenpfeil S, Neiss A, et al. The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ. 2004;5:46–53.
   PubMedGoogle Scholar
• Carapetis JR, Russell DM, Curtis N. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine. 2004;23:755–761.
   PubMed Web of Science ®Google Scholar
• Somekh E, Dalal I, Shohat T, et al. The burden of uncomplicated cases of chickenpox in Israel. J Infect. 2002;45:233–236.
   PubMed Web of Science ®Google Scholar
• Unim B, Saulle R, Boccalini S, et al. Economic evaluation of Varicella vaccination: results of a systematic review. Hum Vaccin Immunother. 2013;9:1932–1942.
   PubMed Web of Science ®Google Scholar
• Varicella and herpes zoster vaccines: WHO position paper, June. Recommendations. Vaccine. 2014;2016(34):198–199.
   Google Scholar
• Kreth HW, Lee BW, Kosuwon P, et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). Biodrugs. 2008;22:387–402.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Gershon A, Gershon M, et al. Primary versus secondary failure after varicella vaccination: implications for interval between 2 doses. Pediatr Infect Dis J. 2013;32:e305–13.
   PubMed Web of Science ®Google Scholar
• Marin M, Guris D, Chaves SS, et al. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–40.
   PubMedGoogle Scholar
• Kurugol Z, Halicioglu O, Koc F, et al. Varicella rates among unvaccinated and one-dose vaccinated healthy children in Izmir, Turkey. Int J Infect Dis. 2011;15:e475–80.
   PubMed Web of Science ®Google Scholar
• Pieri L, Porchia BR, Pieralli F, et al. Assessment of the effectiveness of the universal varicella vaccination program in Toscana (Italy), in the period 2010-2013. Epidemiol Prev. 2015;39:119–123.
   PubMed Web of Science ®Google Scholar
• Spackova M, Wiese-Posselt M, Dehnert M, et al. Comparative varicella vaccine effectiveness during outbreaks in day-care centres. Vaccine. 2010;28:686–691.
   PubMed Web of Science ®Google Scholar
• Tafuri S, Martinelli D, De Palma M, et al. Report of varicella outbreak in a low vaccination coverage group of otherwise healthy children in Italy: the role of breakthrough and the need of a second dose of vaccine. Vaccine. 2010;28:1594–1597.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, et al. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137:1–10.
   Web of Science ®Google Scholar
• Banz K, Iseli A, Aebi C, et al. Economic evaluation of varicella vaccination in Swiss children and adolescents. Hum Vaccin. 2009;5:847–857.
   PubMed Web of Science ®Google Scholar
• Maman K, Zollner Y, Greco D, et al. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11:2132–2141.
   PubMed Web of Science ®Google Scholar
• Holl K, Sauboin C, Amodio E, et al. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health. 2016;16:1103.
   PubMed Web of Science ®Google Scholar
• RGlaxoSmithKline. Varilrix^TM Summary of Product Characteristics 2015. Available from: https://www.medicines.org.uk/emc/medicine/9787. [Accessed on Dec 6th, 2016].
   Google Scholar
• Sanofi Pasteur MSD Limited. Varivax^TM Summary of Product Characteristics 2013. Available from: https://www.medicines.org.uk/emc/medicine/15264. [Accessed on Dec 6th, 2016].
   Google Scholar
• GlaxoSmithKline. Priorix-TetraTM Summary of Product Characteristics 2014. Available from: http://www.hpra.ie/img/uploaded/swedocuments/LicenseSPC_PA1077-117-003_20052014100041.pdf. [Accessed on Dec 6th, 2016].
   Google Scholar
• Sanofi Pasteur MSD ProQuadTM Summary of Product Characteristics 2014. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000622/WC500044070.pdf. [Accessed on Dec 6th, 2016].
   Google Scholar
• Ma SJ, Li X, Xiong YQ, et al. Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety. Medicine (Baltimore). 2015;94:e1721.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhu L, Zhu H. Efficacy of varicella (VZV) vaccination: an update for the clinician. Ther Adv Vaccines. 2016;4:20–31.
   PubMedGoogle Scholar
• Kuter B, Matthews H, Shinefield H, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132–137.
   PubMed Web of Science ®Google Scholar
• Prymula R, Bergsaker MR, Esposito S, et al. Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014;383:1313–1324.
   PubMed Web of Science ®Google Scholar
• Garcia Cenoz M, Castilla J, Chamorro J, et al. Impact of universal two-dose vaccination on varicella epidemiology in Navarre, Spain, 2006 to 2012. Euro Surveill. 2013;18:20552.
   PubMedGoogle Scholar
• Boccalini S, Bonanni P, Bechini A. Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004-2012. Euro Surveill. 2016;21:pii=30257.
   PubMedGoogle Scholar
• Luyten J, Ogunjimi B, Beutels P. Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. Vaccine. 2014;32:7175–7178.
   PubMed Web of Science ®Google Scholar
• Betta M, Laurino M, Pugliese A, et al. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination. Proc Biol Sci. 2016;283:20160054.
   PubMed Web of Science ®Google Scholar
• Gershon AA, Breuer J, Cohen JI, et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1:15016.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health and Ageing. Immunise Australia Program (2016). Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home~handbook10part4~handbook10-4-22. [Accessed on Dec 6th, 2016].
   Google Scholar
• Hanquet G, Valenciano M, Simondon F, et al. Vaccine effects and impact of vaccination programmes in post-licensure studies. Vaccine. 2013;31:5634–5642.
   PubMed Web of Science ®Google Scholar
• Vazquez M, LaRussa PS, Gershon AA, et al. Effectiveness over time of varicella vaccine. Jama. 2004;291:851–855.
   PubMed Web of Science ®Google Scholar
• Mahamud A, Wiseman R, Grytdal S, et al. Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine. 2012;30:6935–6939.
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203:312–315.
   PubMed Web of Science ®Google Scholar
• Liese JG, Cohen C, Rack A, et al. The effectiveness of varicella vaccination in children in Germany: a case-control study. Pediatr Infect Dis J. 2013;32:998–1004.
   PubMed Web of Science ®Google Scholar
• Miron D, Lavi I, Kitov R, et al. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J. 2005;24:233–236.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choe YJ, Cho SI, et al. Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. J Korean Med Sci. 2016;31:1897–1901.
   PubMed Web of Science ®Google Scholar
• Bayer O, Heininger U, Heiligensetzer C, et al. Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine. 2007;25:6655–6660.
   PubMed Web of Science ®Google Scholar
• Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis. 2008;197(Suppl 2):S82–9.
   PubMed Web of Science ®Google Scholar
• Siedler A, Rieck T, Tolksdorf K. Strong additional effect of a second varicella vaccine dose in children in Germany, 2009-2014. J Pediatr. 2016;173:202–206.
   PubMed Web of Science ®Google Scholar
• Fu C, Wang M, Liang J, et al. The effectiveness of varicella vaccine in China. Pediatr Infect Dis J. 2010;29:690–693.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang H, Li K, et al. Single-dose varicella vaccine effectiveness in school settings in China. Vaccine. 2013;31:3834–3838.
   PubMed Web of Science ®Google Scholar
• Baxter R, Ray P, Tran TN, et al. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study. Pediatrics. 2013;131:e1389–96.
   PubMed Web of Science ®Google Scholar
• Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, et al. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination. Expert Rev Vaccines. 2016;16:229–234.
   PubMed Web of Science ®Google Scholar
• Amodio E, Tramuto F, Cracchiolo M, et al. The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003-2012). Hum Vaccin Immunother. 2015;11:236–239.
   PubMed Web of Science ®Google Scholar
• Baxter R, Tran TN, Ray P, et al. Impact of vaccination on the epidemiology of varicella: 1995-2009. Pediatrics. 2014;134:24–30.
   PubMed Web of Science ®Google Scholar
• Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15:pii=19530.
   Google Scholar
• Streng A, Grote V, Carr D, et al. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infect Dis. 2013;13:303.
   PubMed Web of Science ®Google Scholar
• Pozza F, Piovesan C, Russo F, et al. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine. 2011;29:9480–9487.
   PubMed Web of Science ®Google Scholar
• Mullins J, Kudish K, Sosa L, et al. Continuing decline in varicella incidence after the 2-dose vaccination recommendation-connecticut, 2009-2014. Open Forum Infect Dis. 2015;2:ofv150.
   PubMed Web of Science ®Google Scholar
• Jumaan AO, Yu O, Jackson LA, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis. 2005;191:2002–2007.
   PubMed Web of Science ®Google Scholar
• Chao DY, Chien YZ, Yeh YP, et al. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008. Epidemiol Infect. 2012;140:1131–1140.
   PubMed Web of Science ®Google Scholar
• Chang LY, Huang LM, Chang IS, et al. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan. BMC Infect Dis. 2011;11:352.
   PubMed Web of Science ®Google Scholar
• Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010;28:2532–2538.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Brown C, et al. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics. 2011;127:238–245.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R. Impact of the maturing varicella vaccination program on varicella and related outcomes in the United States: 1994-2012. J Pediatric Infect Dis Soc. 2016;5:395–402.
   PubMed Web of Science ®Google Scholar
• Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10:3594–3600.
   PubMed Web of Science ®Google Scholar
• Gil-Prieto R, Walter S, Gonzalez-Escalada A, et al. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014;32:277–283.
   PubMed Web of Science ®Google Scholar
• De Martino Mota A, Carvalho-Costa FA. Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine. J Pediatr (Rio J). 2016;92:361–366.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Baldo V, et al. Impact of universal vaccination against varicella in Italy. Hum Vaccin Immunother. 2015;11:63–71.
   PubMed Web of Science ®Google Scholar
• Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine. 2013;31:4744–4748.
   PubMed Web of Science ®Google Scholar
• Heywood AE, Wang H, Macartney KK, et al. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ. 2014;92:593–604.
   PubMed Web of Science ®Google Scholar
• Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005;352:450–458.
   PubMed Web of Science ®Google Scholar
• Guris D, Jumaan AO, Mascola L, et al. Changing varicella epidemiology in active surveillance sites–United States, 1995-2005. J Infect Dis. 2008;197(Suppl 2):S71–5.
   PubMed Web of Science ®Google Scholar
• Papaloukas O, Giannouli G, Papaevangelou V. Successes and challenges in varicella vaccine. Ther Adv Vaccines. 2014;2:39–55.
   PubMedGoogle Scholar
• Van Hoek AJ, Melegaro A, Zagheni E, et al. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011;29:2411–2420.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Immunization, vaccines and biologicals: varicella (2015). Available from: http://www.who.int/immunization/diseases/varicella/en/ [Accessed on Dec 6th, 2016].
   Google Scholar
• Bialek SR, Perella D, Zhang J, et al. Impact of a routine two-dose varicella vaccination program on varicella epidemiology. Pediatrics. 2013;132:e1134–40.
   PubMed Web of Science ®Google Scholar
• Kuter BJ, Ngai A, Patterson CM, et al. Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group. Vaccine. 1995;13:967–972.
   PubMed Web of Science ®Google Scholar
• Sperber SJ, Smith BV, Hayden FG. Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine. Antiviral Res. 1992;17:213–222.
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ, Gay NJ, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect. 2000;125:651–669.
   PubMed Web of Science ®Google Scholar
• Oxman MN. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence. J Am Osteopath Assoc. 2009;109:S13–7.
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
   PubMedGoogle Scholar
• Horn J, Karch A, Damm O, et al. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016;12:1766–1776.
   PubMed Web of Science ®Google Scholar
• Gidding HF, Brisson M, Macintyre CR, et al. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health. 2005;29:544–551.
   PubMed Web of Science ®Google Scholar
• Karhunen M, Leino T, Salo H, et al. Modelling the impact of varicella vaccination on varicella and zoster. Epidemiol Infect. 2010;138:469–481.
   PubMed Web of Science ®Google Scholar
• Damm O, Ultsch B, Horn J, et al. Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries. BMC Public Health. 2015;15:533.
   PubMed Web of Science ®Google Scholar
• Van Lier A, Lugner A, Opstelten W, et al. Distribution of health effects and cost-effectiveness of varicella vaccination are shaped by the impact on herpes zoster. EBioMedicine. 2015;2:1494–1499.
   PubMed Web of Science ®Google Scholar
• Kawai K, Yawn BP, Wollan P, et al. Increasing Incidence of herpes zoster over a 60-year period from a population-based study. Clin Infect Dis. 2016;63:221–226.
   PubMed Web of Science ®Google Scholar
• Ragozzino MW, Melton LJ 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61:310–316.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341–1349.
   PubMed Web of Science ®Google Scholar
• Nelson MR, Britt HC, Harrison CM. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust. 2010;193:110–113.
   PubMed Web of Science ®Google Scholar
• Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol. 2008;29:1157–1163.
   PubMed Web of Science ®Google Scholar
• Wu PY, Wu HD, Chou TC, et al. Varicella vaccination alters the chronological trends of herpes zoster and varicella. Plos One. 2013;8:e77709.
   PubMed Web of Science ®Google Scholar
• Yih WK, Brooks DR, Lett SM, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health. 2005;5:68.
   PubMed Web of Science ®Google Scholar
• Civen R, Marin M, Zhang J, et al. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, antelope valley, CA, 2000 to 2010. Pediatr Infect Dis J. 2016;35:1132–1136.
   PubMed Web of Science ®Google Scholar
• Jardine A, Conaty SJ, Vally H. Herpes zoster in Australia: evidence of increase in incidence in adults attributable to varicella immunization? Epidemiol Infect. 2011;139:658–665.
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R, Molinari NA, et al. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52:332–340.
   PubMed Web of Science ®Google Scholar
• Tanuseputro P, Zagorski B, Chan KJ, et al. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine. 2011;29:8580–8584.
   PubMed Web of Science ®Google Scholar
• Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;28:954–959.
   PubMed Web of Science ®Google Scholar
• Weinmann S, Chun C, Schmid DS, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis. 2013;208:1859–1868.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Van Damme P, Beutels P. Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review. Plos One. 2013;8:e66485.
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Riedlinger K, Chun C, et al. Incidence of herpes zoster, 1997-2002. Epidemiol Infect. 2005;133:245–253.
   PubMed Web of Science ®Google Scholar
• Hambleton S, Steinberg SP, Larussa PS, et al. Risk of herpes zoster in adults immunized with varicella vaccine. J Infect Dis. 2008;197(Suppl 2):S196–9.
   PubMed Web of Science ®Google Scholar
• Hata A, Asanuma H, Rinki M, et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med. 2002;347:26–34.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Willem L, Beutels P, et al. Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster. Elife. 2015;4:e07116.
   Web of Science ®Google Scholar
• Poletti P, Melegaro A, Ajelli M, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. Plos One. 2013;8:e60732.
   PubMed Web of Science ®Google Scholar
• Wood SM, Shah SS, Steenhoff AP, et al. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006. Pediatrics. 2008;121:e150–6.
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Joesoef MR, et al. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159:739–745.
   PubMed Web of Science ®Google Scholar
• Shirane R, Tang H, Hayashi K, et al. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study. J Med Virol. 2017;89:313–317.
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Theeten H, Hens N, et al. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation. J Med Virol. 2014;86:812–819.
   PubMed Web of Science ®Google Scholar
• Guzzetta G, Poletti P, Merler S, et al. The epidemiology of herpes zoster after varicella immunization under different biological hypotheses: perspectives from mathematical modeling. Am J Epidemiol. 2016;183:765–773.
   PubMed Web of Science ®Google Scholar
• Centro de Vigilancia Epidemiologica “Prof. Alexandre Vranjac”. Calendário de Vacinação (2016). Available from: http://portal.saude.sp.gov.br/resources/cve-centro-de-vigilancia-epidemiologica/areas-de-vigilancia/imunizacao/doc/calendario16_vacinacao.pdf [Accessed on Dec 6th, 2016].
   Google Scholar
• Ministerio de Salud Presidencia de la Nación. Calendario Nacional de Vacunación de la República Argentina 2017. Available from: http://www.msal.gob.ar/index.php/component/content/article/46-ministerio/184-calendario-nacional-de-vacunacion-2016 [Accessed on Feb 22th, 2017].
   Google Scholar
• Tafuri S, Martinelli D, Prato R, et al. Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMV. Hum Vaccin Immunother. 2013;9:184–188.
   PubMed Web of Science ®Google Scholar
• Lai CC, Chen SC, Jiang DD. An outbreak of varicella among schoolchildren in Taipei. BMC Public Health. 2011;11:226.
   PubMed Web of Science ®Google Scholar
• Vazquez M, LaRussa PS, Gershon AA, et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med. 2001;344:955–960.
   PubMed Web of Science ®Google Scholar
• Perella D, Wang C, Civen R, et al. Varicella vaccine effectiveness in preventing community transmission in the 2-dose era. Pediatrics. 2016;137:e20152802.
   PubMed Web of Science ®Google Scholar
• Hohle M, Siedler A, Bader HM, et al. Assessment of varicella vaccine effectiveness in Germany: a time-series approach. Epidemiol Infect. 2011;139:1710–1719.
   PubMed Web of Science ®Google Scholar
• Trucchi C, Gabutti G, Rota MC, et al. Burden of varicella in Italy, 2001-2010: analysis of data from multiple sources and assessment of universal vaccination impact in three pilot regions. J Med Microbiol. 2015;64:1387–1394.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program - United States, 2005-2014. MMWR Morb Mortal Wkly Rep. 2016;65:902–905.
   PubMed Web of Science ®Google Scholar
• Streng A, Grote V, Rack-Hoch A, et al. Decline of neurologic varicella complications in children during the first 7 years after introduction of universal varicella vaccination in Germany, 2005-2011. Pediatr Infect Dis J. 2017;36:79–86.
   PubMed Web of Science ®Google Scholar
• Elbaz M, Paret G, Yohai AB, et al. Immunisation led to a major reduction in paediatric patients hospitalised because of the varicella infection in Israel. Acta Paediatr. 2016;105:e161–6.
   PubMed Web of Science ®Google Scholar
• Humes EA, Weinberger DM, Kudish KS, et al. Trends in hospitalizations with primary varicella and herpes zoster during the prevaricella and initial postvaricella and herpes zoster vaccine eras, connecticut, 1994-2012. Open Forum Infect Dis. 2015;2:ofv001.
   PubMed Web of Science ®Google Scholar
• Marra F, Chong M, Najafzadeh M. Increasing incidence associated with herpes zoster infection in British Columbia, Canada. BMC Infect Dis. 2016;16:589.
   PubMed Web of Science ®Google Scholar